Bibliography

Export 2842 results:
Filters: Filter is   [Clear All Filters]
2012
Quillen K. Hemolysis from platelet transfusion: call to action for an underreported reaction. Transfusion//Transfusion. 2012;52(10):2072-4.
Quillen K, MD MP. Hemolysis from platelet transfusion: call to action for an underreported reaction. //Transfusion. 2012;52(10):2072-2074.
Vermeulen M, Dickens C, Lelie N, Walker E, Coleman C, Keyter M, et al. Hepatitis B virus transmission by blood transfusion during 4 years of individual-donation nucleic acid testing in South Africa: estimated and observed window period risk. Transfusion// Transfusion. 2012;52(4):880-92.
HFEA. HFEA Adverse incidents in fertility clinics lessons to learn 2010-2012. London: HFEA - Human Fertilisation and Embryology Authority; 2012.
Armstrong MJ, Corbett C, Rowe IA, Taylor GP, Neuberger JM. HTLV-1 in solid-organ transplantation: current challenges and future management strategies. Transplantation// Transplantation. 2012;94(11):1075-84.
Gobbini F, Owusu-Ofori S, Marcelin A-, Candotti D, Allain J-. Human herpesvirus 8 transfusion transmission in Ghana, an endemic region of West Africa. Transfusion// Transfusion. 2012;52(11):2294-9.
von Boehmer L, Draenert A, Jungraithmayr W, Inci I, Niklaus S, Boehler A, et al. Immunosuppression and lung cancer of donor origin after bilateral lung transplantation.. 2012;76(1):8.
Sampaio MS, Cho YW, Shah T, Bunnapradist S, Hutchinson IV. Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association// Nephrol Dial Transplant. 2012;27(7):2971-9.
Singh N, Neidlinger N, Djamali A, Leverson G, Voss B, Sollinger HW, et al. The impact of hepatitis C virus donor and recipient status on long-term kidney transplant outcomes: University of Wisconsin experience. ClinTransplant. 2012;26(5):84.
Andraus W, Pugliese V, Pecora R, D'Albuquerque L. Intentional use of Schistosoma mansoni-infected grafts in living donor liver transplantation.. 2012;18(7):867-868.
Goldaracena N, Wolf MM, Quinonez E, Anders M, Mastai R, McCormack L. Is it safe to use a liver graft from a Chagas disease-seropositive donor in a human immunodeficiency virus-positive recipient? A case report addressing a novel challenge in liver transplantation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society//Liver Transpl. 2012;18(8):979-83.
Pintova S, Bhardwaj AS, Aledort LM. IVIG--a hemolytic culprit. N Engl J Med. 2012;367(10):4.
Ausania F, White SA, Pocock P, Manas DM. Kidney damage during organ recovery in donation after circulatory death donors: data from UK National Transplant Database. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons// Am J Transplant. 2012;12(4):932-6.
Schlosser B, Stein A, Neuhaus R, Pahl S, Ramez B, Kruger DH, et al. Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient. Journal of hepatology//J Hepatol. 2012;56(2):500-2.
McCormack L., Quinonez E., Goldaracena N., Anders M., Rodriguez V., F. Ganem O, et al. Liver Transplantation Using Chagas-Infected Donors in Uninfected Recipients: A Single-Center Experience Without Prophylactic Therapy. Vol 12.; 2012.
M Hijosa M, A Melgar A, Urrutia MJ, C Meseguer G, E Monereo J, M Torres N. Living-donor transplantation after excision of unrecognized renal cancer diagnosed after transplant. Pediatr Nephrol. 2012;27(12):9.
Johnson ST, Cable RG, Leiby DA. Lookback investigations of Babesia microti-seropositive blood donors: seven-year experience in a Babesia-endemic area. Transfusion// Transfusion. 2012;52(7):1509-16.
Haagerup A. A mosaic sperm donor fathers a large group of half sibs with NF1. Rapid Response Re: Danish sperm donor passed neurofibromatosis on to five children . BMJ. 2012;345.
Tomblyn M, Chen M, Kukreja M, Aljurf MD, F Mohareb A, Bolwell BJ, et al. No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantation. Transpl Infect Dis. 2012;14(5):6.
de Boer M, Vink A, van de Graaf EA. Non-small cell lung carcinoma of donor origin after bilateral lung transplantation. Lung Cancer. 2012;76(2):59.
Goldberg E., Bishara J., Lev S., Singer P., Cohen J.. Organ transplantation from a donor colonized with a multidrug-resistant organism: a case report. //Transpl Infect Dis. 2012;14(3):296-299.
Ariza-Heredia E., Patel R., Blumberg E., Walker R., Lewis R., Evans J., et al. Outcomes of transplantation using organs from a donor infected with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae. //Transpl Infect Dis. 2012;14(3):229-236.
Mejia R., Booth G., Fedorko D., Hsieh M., Khuu H., Klein HG, et al. Peripheral blood stem cell transplant-related Plasmodium falciparum infection in a patient with sickle cell disease.. Vol 52. United States; 2012. (Transfusion; vol 52; no 12).
Brown JH, Tellez J, Wilson V, Mackie IJ, Scully M, Tredger MM, et al. Postpartum aHUS secondary to a genetic abnormality in factor H acquired through liver transplantation. Am J Transplant. 2012;12(6):2.
Kulkarni A, Sinha M, Anandh U. Primary cutaneous cryptococcosis due to Cryptococcous laurentii in a renal transplant recipient. Saudi JKidney DisTranspl. 2012;23(1):2.

Pages